Brain Monitoring Devices Market Poised for Steady Growth, Fueled by Innovation and Rising Surgical Volumes | DelveInsight

The brain monitoring devices market, valued at USD 5.89 billion in 2023, is projected to grow at a CAGR of 7.27% from 2024 to 2030, reaching USD 9.13 billion by 2030. Growth is driven by the rising prevalence of neurological disorders such as multiple sclerosis, epilepsy, and dementia, along with increasing awareness and ongoing product development activities, all contributing to the market's expansion during the forecast period.

DelveInsight's Brain Monitoring Devices Market Insights report provides the current and forecast market analysis, individual leading Brain Monitoring Devices companies' market shares, challenges, Brain Monitoring Devices market drivers, barriers, and trends, and key Brain Monitoring Devices companies in the market.

Request for a sample page report @ https://www.delveinsight.com/report-store/brain-monitoring-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Key Takeaways from the Brain Monitoring Devices Market Report
The Brain Monitoring Devices market is projected to grow at a moderate CAGR from 2025 to 2032.
As per DelveInsight estimates, North America is anticipated to dominate the global Brain Monitoring Devices market during the forecast period.
Notable Brain Monitoring Devices companies such as Medtronic, Nonin, Raumedic AG, Natus Medical Incorporated, Edwards Lifesciences Corporation, BrainScope Company Inc., NIHON KOHDEN CORPORATION, Neurosoft, Advanced Brain Monitoring Inc., Rimed, Masimo, NeuroWave Systems Inc., Compumedics Limited, Spiegelberg GmbH & Co. KG, NOVASIGNAL CORPORATION, and several others are currently operating in the Brain Monitoring Devices market.
In June 2024, Zeto secured FDA clearance for its user-friendly EEG brain monitoring system, featuring a comfortable headset that can be operated by medical professionals with minimal training.
In April 2024, NeuroVigil introduced the iBrain personal brain monitor in the U.S., an investigational portable device for noninvasive recording of brain electrical activity in individuals with neurological disorders.
In May 2024, Neurable raised $13 million to advance its non-invasive brain-computer interface (BCI) technology, which uses EEG and AI in a compact design to capture and analyze brain activity data.
In April 2021, Integra LifeSciences Corporation received FDA 510(k) clearance for its CereLink ICP Monitor, designed to interface between standard physiological pressure monitoring systems and compatible strain-gauge pressure transducers.

To read more about the latest highlights related to the Brain Monitoring Devices market, get a snapshot of the key highlights entailed in the Global Brain Monitoring Devices Market Report https://www.delveinsight.com/sample-request/brain-monitoring-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Brain Monitoring Devices Overview

Brain monitoring devices are medical tools used to record and analyze electrical activity, blood flow, pressure, and other parameters related to brain function. They play a vital role in diagnosing neurological disorders, monitoring disease progression, guiding treatments, and assessing patient recovery in clinical and research settings.

Brain Monitoring Devices Market Insights

North America is expected to command a significant share of the brain monitoring devices market from 2024 to 2030, driven by the rising incidence of Parkinson's disease, increasing cases of traumatic brain injuries, and active product development supported by regulatory bodies. The presence of leading brain monitoring device manufacturers in the region further boosts market growth.

According to the Parkinson's Foundation (2024), nearly one million people in the U.S. currently live with Parkinson's disease-a figure projected to reach 1.2 million by 2030. As the second most common neurodegenerative disorder after Alzheimer's, Parkinson's sees about 90,000 new U.S. diagnoses each year. Brain monitoring devices are vital for diagnosing the disease, tracking its progression, and assessing treatment effectiveness. They offer critical insights into motor symptoms and cognitive function, enabling personalized care and the creation of targeted therapies.

To know more about why North America is leading the market growth in the Brain Monitoring Devices market, get a snapshot of the Brain Monitoring Devices Market Outlook https://www.delveinsight.com/report-store/brain-monitoring-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Brain Monitoring Devices Market Dynamics

According to the World Health Organization (WHO) 2023 data, over 1.8 million people worldwide are affected by multiple sclerosis (MS), a condition that impairs cognitive, emotional, motor, sensory, and visual functions due to the immune system attacking the brain and spinal cord. Brain monitoring devices play a crucial role in tracking brain activity and function, aiding in diagnosis, monitoring disease progression, and evaluating treatment effectiveness, thereby enabling more personalized care.

WHO data from 2024 also indicates that around 50 million people globally live with epilepsy, making it one of the most prevalent neurological disorders, with nearly 80% residing in low- and middle-income countries. Up to 70% of epilepsy cases could be seizure-free with proper diagnosis and treatment. Annually, an estimated 5 million new cases are reported worldwide, with incidence rates of about 49 per 100,000 in high-income countries and up to 139 per 100,000 in low- and middle-income regions. Brain monitoring devices assist in diagnosing epilepsy, tracking seizure activity, guiding treatment, and assessing therapy response, thereby improving overall condition management.


Brain Monitoring Devices Market Drivers:
Increasing instances of neurological disorders
Rising product developmental activities

Get a sneak peek at the Brain Monitoring Devices market dynamics @ https://www.delveinsight.com/sample-request/brain-monitoring-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Scope of the Brain Monitoring Devices Market Report:
Coverage: Global
Study Period: 2022 to 2032
Key Brain Monitoring Devices Companies: Medtronic, Nonin, Raumedic AG, Natus Medical Incorporated, Edwards Lifesciences Corporation, BrainScope Company Inc., NIHON KOHDEN CORPORATION, Neurosoft, Advanced Brain Monitoring Inc., Rimed, Masimo, NeuroWave Systems Inc., Compumedics Limited, Spiegelberg GmbH & Co. KG, NOVASIGNAL CORPORATION, and others.

Which MedTech key players in the Brain Monitoring Devices market are set to emerge as the trendsetter, explore @ Brain Monitoring Devices Companies https://www.delveinsight.com/report-store/brain-monitoring-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Contact Info:

Kritika Rehani
Assistant Manager, Digital Marketing & Branding
krehani@delveinsight.com
info@delveinsight.com
www.delveinsight.com
+14699457679

About DelveInsight

DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.

Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

This release was published on openPR.